Coherus BioSciences Inc at Barclays Global Healthcare Conference Transcript
Good afternoon, everyone. So continuing the afternoon session for the day, we have with us the management from Coherus. And we have Dennis Lanfear, CEO; and Rosh Dias, CMO; and of course, Paul Reider Chief Commercial Officer. Dennis, Paul and Rosh, thanks so much for taking your time to join us today.
Thank you. Thank you very much, and thank you once again for your invitation. It's nice to be here in Miami.
Of course, absolutely. (inaudible) meetings. So since you reported a couple of weeks ago, why don't we up with recapping some of the key highlights from the earnings call and [risk focus before we go to Q&A].
Sure. I'd be happy to do that. That's in 2022, we made substantial progress on our overarching strategy with respect to the development of our other, our IO portfolio with sales
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
